This module aims to inform healthcare practitioners on the mechanisms of HIV drug resistance, factors which contribute to drug resistances and the clinical consequences. This learning module is part of an independent medical education programme funded by Gilead. Gilead employees do not have access to the MedShr platform

Explain the mechanisms of HIV drug resistance: Learn how HIV acquires resistance to antiretroviral drugs and the molecular mechanisms involved in the development of resistance and be able to select drugs that are less likely to be affected by drug resistance mutations.

Identify the factors that contribute to HIV drug resistance: Learn about the patient, viral, and drug factors that increase the risk of developing drug resistance in HIV-positive individuals. Apply this knowledge to monitor patients who are at higher risk for developing resistance and to modify treatment regimens as needed.

Understand the clinical consequences of HIV drug resistance and identify patients who are at risk of developing resistance: Learn about the impact of drug resistance on the efficacy of antiretroviral therapy, disease progression and patient outcomes.

HIV Drug Resistance - Part 1 

HIV Education Group

HIV and drug resistance

HIV drug resistance, clinical implications and strategies to prevent and manage resistance. 

MedShr Editor

The second part of this learning series will focus on strategies for preventing the development of HIV drug resistance including disease prevention, rapid diagnosis, population monitoring and resistance testing. 

HIV Drug Resistance - Part 2 

This learning series has been created to inform health care practitioners about HIV drug resistance, the clinical implications and strategies to prevent and manage resistance. This Learning series has been sponsored by Gilead. Gilead employees do not have access to the MedShr Platform.